HIV: Cell Binding and Entry

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

Feng, Y. Y., Broder, C. C., Kennedy, P. E., & Berger, E. A. (1996) · Science · doi:10.1126/science.272.5263.872 · Cited by 4,169

Identification of a major co-receptor for primary isolates of HIV-1

Deng, H., Liu, R., Ellmeier, W., Choe, S. S., Unutmaz, D., Burkhart, M. D., Marzio, P. D., Marmon, S., Sutton, R. E., Hill, C. M., et al. (1996) · Nature · doi:10.1038/381661a0 · Cited by 3,640

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

Dragic, T., Litwin, V., Allaway, G. P., Martin, S. R., Huang, Y., Nagashima, K. A., Cayanan, C. S., Maddon, P. J., Koup, R. A., Moore, J. P., et al. (1996) · Nature · doi:10.1038/381667a0 · Cited by 3,173

Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection

Liu, R., Paxton, W. A., Choe, S., Ceradini, D., Martin, S. R., Horuk, R., MacDonald, M. E., Stuhlmann, H., Koup, R. A., & Landau, N. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80110-5 · Cited by 3,074

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

Kwong, P. D., Wyatt, R. T., Robinson, J. E., Sweet, R. W., Sodroski, J., & Hendrickson, W. A. (1998) · Nature · doi:10.1038/31405 · Cited by 2,963

Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

Samson, M., Libert, F., Doranz, B. J., Rucker, J. B., Liesnard, C., Farber, C., Saragosti, S., Lapouméroulie, C., Cognaux, J., Forceille, C., et al. (1996) · Nature · doi:10.1038/382722a0 · Cited by 2,885

Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T Cells

Cocchi, F., DeVico, A. L., Demo, A. G., Arya, S. K., Gallo, R. C., & Lusso, P. (1995) · Science · doi:10.1126/science.270.5243.1811 · Cited by 2,867

Pneumocystis cariniiPneumonia and Mucosal Candidiasis in Previously Healthy Homosexual Men

Gottlieb, M. S., Schroff, R. W., Schanker, H. M., Weisman, J. D., Fan, P. T., Wolf, R. A., & Saxon, A. (1981) · New England Journal of Medicine · doi:10.1056/nejm198112103052401 · Cited by 2,723

CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1

Alkhatib, G., Combadière, C., Broder, C. C., Feng, Y., Kennedy, P. E., Murphy, P. M., & Berger, E. A. (1996) · Science · doi:10.1126/science.272.5270.1955 · Cited by 2,703

Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene

Dean, M. C., Carrington, M. N., Winkler, C. A., Huttley, G. A., Smith, M. W., Allikmets, R. L., Goedert, J. J., Buchbinder, S., Vittinghoff, E., Gomperts, E. D., et al. (1996) · Science · doi:10.1126/science.273.5283.1856 · Cited by 2,503

Telomere and ATM Dynamics in CD4 T-Cell Depletion in Active and Virus-Suppressed HIV Infections

Khanal, S., Tang, Q., Cao, D., Zhao, J., Nguyen, L. N., Oyedeji, O., Dang, X., Nguyen, L. N. T., Schank, M., Thakuri, B. K. C., et al. (2020) · Journal of Virology · doi:10.1128/jvi.01061-20 · Cited by 21

A SERS based clinical study on HIV-1 viral load quantification and determination of disease prognosis

Yadav, S., Senapati, S., Kulkarni, S., & Singh, J. P. (2022) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2022.112629 · Cited by 20

Engineering antibody-like inhibitors to prevent and treat HIV-1 infection

Gardner, M. R., & Farzan, M. (2017) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000367 · Cited by 21

How to win the HIV-1 drug resistance hurdle race: running faster or jumping higher?

Garbelli, A., Riva, V., Crespan, E., & Maga, G. (2017) · Biochemical Journal · doi:10.1042/bcj20160772 · Cited by 22

SUN1 Regulates HIV-1 Nuclear Import in a Manner Dependent on the Interaction between the Viral Capsid and Cellular Cyclophilin A

Luo, X., Yang, W., & Gao, G. (2018) · Journal of Virology · doi:10.1128/jvi.00229-18 · Cited by 20

Pharmaceutical Approaches to HIV Treatment and Prevention

Yavuz, B., Morgan, J. L., Showalter, L., Crakes, K. R., Dandekar, S., Herrera, C., LiWang, P. J., & Kaplan, D. L. (2018) · Advanced Therapeutics · doi:10.1002/adtp.201800054 · Cited by 22

Current Computational Approaches for the Development of Anti-HIV Inhibitors: An Overview

Panwar, U., Chandra, I., Selvaraj, C., & Singh, S. K. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190911160244 · Cited by 20

The Genome-wide Methylation Profile of CD4+ T Cells From Individuals With Human Immunodeficiency Virus (HIV) Identifies Distinct Patterns Associated With Disease Progression

Morón‐López, S., Urrea, V., Dalmau, J., López, M., Puertas, M. C., Ouchi, D., Gómez, A., Passaes, C., Mothe, B., Brander, C., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1047 · Cited by 19

Ubiquitination and SUMOylation in HIV Infection: Friends and Foes

Colomer-Lluch, M., Castro‐Gonzalez, S., & Serra-Moreno, R. (2019) · Current Issues in Molecular Biology · doi:10.21775/cimb.035.159 · Cited by 21

HIV Infection Predisposes to Increased Chances of HBV Infection: Current Understanding of the Mechanisms Favoring HBV Infection at Each Clinical Stage of HIV Infection

Zaongo, S. D., Ouyang, J., Chen, Y., Jiao, Y., Wu, H., & Chen, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.853346 · Cited by 20

Trehalose Inhibits Human Immunodeficiency Virus Type 1 Infection in Primary Human Macrophages and CD4 + T Lymphocytes through Two Distinct Mechanisms

Rawat, P., Hon, S., Teodorof‐Diedrich, C., & Spector, S. A. (2020) · Journal of Virology · doi:10.1128/jvi.00237-20 · Cited by 19

Targeted microbicides for preventing sexual HIV transmission

Coutinho, C., Sarmento, B. F. C. C., & das Neves, J. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.09.030 · Cited by 19

Pancreatogenic Diabetes: Triggering Effects of Alcohol and HIV

New‐Aaron, M., Ganesan, M., Dagur, R. S., Kharbanda, K. K., Poluektova, L. Y., & Osna, N. A. (2021) · Biology · doi:10.3390/biology10020108 · Cited by 18

Active Components from Cassia abbreviata Prevent HIV-1 Entry by Distinct Mechanisms of Action

Zheng, Y., Yang, X., Schols, D., Mori, M., Botta, B., Chevigné, A., Mulinge, M. M., Steinmetz, A. A., Schmit, J., & Seguin‐Devaux, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22095052 · Cited by 18

CRISPR Technology in Gene-Editing-Based Detection and Treatment of SARS-CoV-2

Shademan, B., Nourazarian, A., Hajazimian, S., Isazadeh, A., Avci, Ç. B., & Oskouee, M. A. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.772788 · Cited by 18

Get in and get out: Remodeling of the cellular actin cytoskeleton upon HIV‐1 infection

Serrano, T., Frémont, S., & Échard, A. (2023) · Biology of the Cell · doi:10.1111/boc.202200085 · Cited by 19

Neurological Complications Caused by Human Immunodeficiency Virus (HIV) and Associated Opportunistic Co-infections: A Review on their Diagnosis and Therapeutic Insights

Balaji, S., Chakraborty, R., & Aggarwal, S. S. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666230330083708 · Cited by 18

Mannose-specific plant and microbial lectins as antiviral agents: A review

Gupta, A., Yadav, K., Yadav, A., Ahmad, R., Srivastava, A., Kumar, D., Khan, M. A., & Dwivedi, U. N. (2024) · Glycoconjugate Journal · doi:10.1007/s10719-023-10142-7 · Cited by 19

Periluminal Distribution of HIV-Binding Target Cells and Gp340 in the Oral, Cervical and Sigmoid/Rectal Mucosae: A Mapping Study

Patyka, M., Malamud, D., Weissman, D., Abrams, W. R., & Kurago, Z. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132942 · Cited by 18

QSAR and molecular docking studies of indole-based analogs as HIV-1 attachment inhibitors

Hdoufane, I., Stoycheva, J., Tadjer, A., Villemin, D., Najdoska-Bogdanov, M., Bogdanov, J. B., & Cherqaoui, D. (2019) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2019.05.056 · Cited by 18

Structural analysis of pleomorphic and asymmetric viruses using cryo-electron tomography and subtomogram averaging

Obr, M., & Schur, F. K. M. (2019) · Advances in virus research · doi:10.1016/bs.aivir.2019.07.008 · Cited by 19

Elucidating the Basis for Permissivity of the MT-4 T-Cell Line to Replication of an HIV-1 Mutant Lacking the gp41 Cytoplasmic Tail

Fernandez, M. V., Hoffman, H. K., Pezeshkian, N., Tedbury, P. R., van Engelenburg, S. B., & Freed, E. O. (2020) · Journal of Virology · doi:10.1128/jvi.01334-20 · Cited by 16

Microbiota-Meditated Immunity Abnormalities Facilitate Hepatitis B Virus Co-Infection in People Living With HIV: A Review

Ouyang, J., Zaongo, S. D., Zhang, X., Qi, M., Hu, A., Wu, H., & Chen, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.755890 · Cited by 18

Plant-Derived Epi-Nutraceuticals as Potential Broad-Spectrum Anti-Viral Agents

Gabbianelli, R., Shahar, E., de Simone, G., Rucci, C., Bordoni, L., Feliziani, G., Zhao, F., Ferrati, M., Maggi, F., Spinozzi, E., et al. (2023) · Nutrients · doi:10.3390/nu15224719 · Cited by 20

CNS Viral Infections—What to Consider for Improving Drug Treatment: A Plea for Using Mathematical Modeling Approaches

Sun, M., Manson, M. L., Guo, T., & de Lange, E. C. M. (2024) · CNS Drugs · doi:10.1007/s40263-024-01082-3 · Cited by 18

Mycobacterium tuberculosis–Human Immunodeficiency Virus Infection and the Role of T Cells in Protection

Hosseinian, K., Gerami, A., Bral, M., & Venketaraman, V. (2024) · Vaccines · doi:10.3390/vaccines12070730 · Cited by 17

Mechanisms and Factors That Drive Extensive Human Immunodeficiency Virus Type-1 Hypervariability: An Overview

Yaseen, M. M., Abuharfeil, N. M., Alqudah, M. A. Y., & Yaseen, M. M. (2017) · Viral Immunology · doi:10.1089/vim.2017.0065 · Cited by 17

Human Three Prime Repair Exonuclease 1 Promotes HIV-1 Integration by Preferentially Degrading Unprocessed Viral DNA

Davids, B.-O., Balasubramaniam, M., Sapp, N., Prakash, P., Ingram, S., Li, M., Craigie, R., Hollis, T., Pandhare, J., & Dash, C. (2021) · Journal of Virology · doi:10.1128/jvi.00555-21 · Cited by 16

P-Selectin Glycoprotein Ligand 1: A Potential HIV-1 Therapeutic Target

Zaongo, S. D., Liu, Y., Harypursat, V., Song, F., Xia, H., Ma, P., & Chen, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.710121 · Cited by 17

Distinct conformations of the HIV-1 V3 loop crown are targetable for broad neutralization

Friedrich, N., Stiegeler, E., Glögl, M., Lemmin, T., Hansen, S., Kadelka, C., Wu, Y., Erñst, P., Maliqi, L., Foulkes, C., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27075-0 · Cited by 16

Preclinical discovery and development of maraviroc for the treatment of HIV

Veljković, N., Vučićević, J., Tassini, S., Glišić, S., Veljković, V., & Radi, M. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.1041497 · Cited by 17

Opening the HIV envelope: potential of CD4 mimics as multifunctional HIV entry inhibitors

Laumaea, A., Smith, A. B., Sodroski, J., & Finzi, A. (2020) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000637 · Cited by 17

Emerging role of cyclophilin A in HIV-1 infection: from producer cell to the target cell nucleus

Padron, A., Prakash, P., Pandhare, J., Luban, J., Aiken, C., Balasubramaniam, M., & Dash, C. (2023) · Journal of Virology · doi:10.1128/jvi.00732-23 · Cited by 19

Mimicking Protein–Protein Interactions through Peptide–Peptide Interactions: HIV-1 gp120 and CXCR4

Groß, A., Möbius, K., Haußner, C., Donhauser, N., Schmidt, B., & Eichler, J. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00257 · Cited by 16

Anti-HIV Activities of Intramolecular G4 and Non-G4 Oligonucleotides

Prokofjeva, M. M., Цветков, В. Б., Викторович, Б. Д., Varizhuk, A. M., Lagarkova, M. A., Smirnov, I. P., Prusakov, K. A., Klinov, D. V., Prassolov, V., Pozmogova, G. E., et al. (2016) · Nucleic Acid Therapeutics · doi:10.1089/nat.2016.0624 · Cited by 16

HIV Entry and Its Inhibition by Bifunctional Antiviral Proteins

Falkenhagen, A., & Joshi, S. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.09.003 · Cited by 16

A unique class of lignin derivatives displays broad anti-HIV activity by interacting with the viral envelope

Oeyen, M., Noppen, S., Vanhulle, E., Claes, S., Myrvold, B. O., Vermeire, K., & Schols, D. (2019) · Virus Research · doi:10.1016/j.virusres.2019.197760 · Cited by 16

xCT/SLC7A11 antiporter function inhibits HIV-1 infection

Rabinowitz, J., Sharifi, H. J., Martin, H., Marchese, A. M., Robek, M. D., Shi, B., Mongin, A. A., & de Noronha, C. M. C. (2021) · Virology · doi:10.1016/j.virol.2021.01.008 · Cited by 17

Single-Molecule Super-Resolution Imaging of T-Cell Plasma Membrane CD4 Redistribution upon HIV-1 Binding

Yuan, Y., Jacobs, C., Llorente‐Garcia, I., Pereira, P. M., Lawrence, S. P., Laine, R. F., Marsh, M., & Henriques, R. (2021) · Viruses · doi:10.3390/v13010142 · Cited by 16

HIV cure: Are we going to make history?

Payra, S., Manjhi, P. K., Singh, S., Kumar, R., Singh, S. K., Kumar, A., & Maharshi, V. (2023) · HIV Medicine · doi:10.1111/hiv.13557 · Cited by 16

Helper T cell immunity in humans with inherited CD4 deficiency

Guérin, A., Moncada‐Vélez, M., Jackson, K., Ogishi, M., Rosain, J., Mancini, M., Langlais, D., Nunez, A. C., Webster, S., Goyette, J., et al. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20231044 · Cited by 15

Host cell glycosylation selects for infection with CCR5- versus CXCR4-tropic HIV-1

Itell, H. L., Guenthoer, J., Humes, D. G., Baumgarten, N. E., & Overbaugh, J. M. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01806-7 · Cited by 15

Preferential recognition of monomeric CCR5 expressed in cultured cells by the HIV-1 envelope glycoprotein gp120 for the entry of R5 HIV-1

Nakano, Y., Monde, K., Terasawa, H., Yuan, Y., Yusa, K., Harada, S., & Maeda, Y. (2014) · Virology · doi:10.1016/j.virol.2013.12.034 · Cited by 15

Neutralization Synergy between HIV-1 Attachment Inhibitor Fostemsavir and Anti-CD4 Binding Site Broadly Neutralizing Antibodies against HIV

Zhang, Y., Chapman, J. H., Ülçay, A., & Sutton, R. E. (2018) · Journal of Virology · doi:10.1128/jvi.01446-18 · Cited by 15

Concomitant Enhancement of HIV-1 Replication Potential and Neutralization-Resistance in Concert With Three Adaptive Mutations in Env V1/C2/C4 Domains

Doi, N., Yokoyama, M., Koma, T., Kotani, O., Sato, H., Adachi, A., & Nomaguchi, M. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00002 · Cited by 15

Membrane organization of virus and target cell plays a role in HIV entry

Dumas, F., Preira, P., & Salomé, L. (2014) · Biochimie · doi:10.1016/j.biochi.2014.08.015 · Cited by 18

Cryo-electron microscopy and single molecule fluorescent microscopy detect CD4 receptor induced HIV size expansion prior to cell entry

Pham, S. T., Tabarin, T., Garvey, M., Pade, C., Rossy, J., Monaghan, P., Hyatt, A. D., Böcking, T., Leis, A. P., Gaus, K., et al. (2015) · Virology · doi:10.1016/j.virol.2015.09.006 · Cited by 15

An Overview of Human Immunodeficiency Virus Type 1-Associated Common Neurological Complications: Does Aging Pose a Challenge?

Nookala, A. R., Mitra, J., Chaudhari, N. S., Hegde, M. L., & Kumar, A. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170473 · Cited by 15

Perioperative Antiretroviral Regimen for HIV/AIDS Patients Who Underwent Abdominal Surgery

Yang, J., Wei, G., He, Y., Hua, X., Feng, S., Zhao, Y., Chen, T., Wang, H., & Guo, L. (2020) · World Journal of Surgery · doi:10.1007/s00268-020-05402-8 · Cited by 15

Bioinspired Structures and Design

Askarinejad, S., & Rahbar, N. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139058995 · Cited by 15

Mesenchymal Stromal Cells: a Possible Reservoir for HIV-1?

Kallmeyer, K., Ryder, M. A., & Pepper, M. S. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10298-5 · Cited by 14

Endocytosed HIV-1 Envelope Glycoprotein Traffics to Rab14+Late Endosomes and Lysosomes to Regulate Surface Levels in T-Cell Lines

Hoffman, H. K., Aguilar, R. S., Clark, A. R., Groves, N. S., Pezeshkian, N., Bruns, M. M., & van Engelenburg, S. B. (2022) · Journal of Virology · doi:10.1128/jvi.00767-22 · Cited by 14

The Triple Threat of HIV-1 Protease Inhibitors

Potempa, M., Lee, S.-K., Wolfenden, R. V., & Swanstrom, R. I. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_438 · Cited by 15

The CD4 Receptor: An Indispensable Protein in T Cell Activation and A Promising Target for Immunosuppression

Claeys, E., & Vermeire, K. (2019) · Archives of Microbiology & Immunology · doi:10.26502/ami.93650036 · Cited by 14

Augmenting the Immune Response against a Stabilized HIV-1 Clade C Envelope Trimer by Silica Nanoparticle Delivery

Peterhoff, D., Thalhauser, S., Sobczak, J. M., Mohsen, M. O., Voigt, C., Seifert, N., Neckermann, P., Hauser, A., Ding, S.-W., Sattentau, Q. J., et al. (2021) · Vaccines · doi:10.3390/vaccines9060642 · Cited by 14

Molecular Gymnastics: Mechanisms of HIV-1 Resistance to CCR5 Antagonists and Impact on Virus Phenotypes

Roche, M., Borm, K., Flynn, J. K., Lewin, S. R., Churchill, M. J., & Gorry, P. R. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150901114724 · Cited by 13

HIV-1 Env and Nef Cooperatively Contribute to Plasmacytoid Dendritic Cell Activation via CD4-Dependent Mechanisms

Reszka-Blanco, N., Sivaraman, V., Zhang, L., & Su, L. (2015) · Journal of Virology · doi:10.1128/jvi.00695-15 · Cited by 13

Determination of HIV tropism and its use in the clinical practice

Pérez‐Olmeda, M., & Alcamı́, J. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2013.852469 · Cited by 13

Development of synthetic light-chain antibodies as novel and potent HIV fusion inhibitors

Cunha-Santos, C., Figueira, T. N., Borrego, P., Oliveira, S. S., Rocha, C., Couto, A., Cantante, C., Santos‐Costa, Q., Azevedo‐Pereira, J. M., Fontes, C. M. G. A., et al. (2016) · AIDS · doi:10.1097/qad.0000000000001108 · Cited by 13

Combining 25-Hydroxycholesterol with an HIV Fusion Inhibitor Peptide: Interaction with Biomembrane Model Systems and Human Blood Cells

Gomes, B., Sanna, G., Madeddu, S., Hollmann, A., & Santos, N. C. (2019) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.8b00321 · Cited by 13

A cross-sectional study to characterize local HIV-1 dynamics in Washington, DC using next-generation sequencing

Gibson, K. M., Jair, K., Castel, A. D., Bendall, M. L., Wilbourn, B. C., Jordan, J. A., Crandall, K. A., Pérez‐Losada, M., Subramanian, T., Binkley, J., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-58410-y · Cited by 13

Inducing chimeric antigen receptor (CAR) regulatory T cells in-vivo: A novel concept for a potential feasible cure of demyelinating diseases

Sedaghat, N., & Etemadifar, M. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103341 · Cited by 13

HIV-1-Mediated Acceleration of Oncovirus-Related Non-AIDS-Defining Cancers

Proulx, J. M., Ghaly, M., Park, I.-W., & Borgmann, K. (2022) · Biomedicines · doi:10.3390/biomedicines10040768 · Cited by 12

A combination HIV reporter virus system for measuring post-entry event efficiency and viral outcome in primary CD4+ T cell subsets

Tilton, C. A., Tabler, C. O., Lucera, M. B., Marek, S. L., Haqqani, A. A., & Tilton, J. C. (2013) · Journal of Virological Methods · doi:10.1016/j.jviromet.2013.08.029 · Cited by 13

Bifunctional Chimera That Coordinately Targets Human Immunodeficiency Virus 1 Envelope gp120 and the Host-Cell CCR5 Coreceptor at the Virus–Cell Interface

Rashad, A. A., Song, L., Holmes, A. P., Acharya, K., Zhang, S., Wang, Z., Gary, E. N., Xie, X., Pirrone, V., Kutzler, M. A., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00477 · Cited by 13

Clonal analysis of HIV-1 genotype and function associated with virologic failure in treatment-experienced persons receiving maraviroc: Results from the MOTIVATE phase 3 randomized, placebo-controlled trials

Lewis, M., Mori, J., Toma, J., Mosley, M., Huang, W., Simpson, P., Mansfield, R., Craig, C., van der Ryst, E., Robertson, D. L., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204099 · Cited by 13

Antibody-dependent cellular cytotoxicity targeting CD4-inducible epitopes predicts mortality in HIV-infected infants

Naiman, N. E., Slyker, J. A., Richardson, B. A., John-Stewart, G. C., Nduati, R. W., & Overbaugh, J. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.08.072 · Cited by 13

Aptamers in Virology—A Consolidated Review of the Most Recent Advancements in Diagnosis and Therapy

Yadavalli, T., Volety, I., & Shukla, D. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101646 · Cited by 13

Anti-HIV Activity of Snake Venom Phospholipase A2s: Updates for New Enzymes and Different Virus Strains

Siniavin, A. E., Grinkina, S. D., Osipov, A. V., Starkov, V. G., Tsetlin, V. I., & Utkin, Y. N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031610 · Cited by 13

Milk Transmission of Mammalian Retroviruses

Kemeter, L. M., Birzer, A., Heym, S., & Thoma‐Kress, A. K. (2023) · Microorganisms · doi:10.3390/microorganisms11071777 · Cited by 13

The Polar Region of the HIV-1 Envelope Protein Determines Viral Fusion and Infectivity by Stabilizing the gp120-gp41 Association

Lu, W., Chen, S., Yu, J., Behrens, R. T., Wiggins, J., Sherer, N. M., Liu, S., Xiong, Y., Xiang, S.-H., & Wu, L. J. (2019) · Journal of Virology · doi:10.1128/jvi.02128-18 · Cited by 12

High affinity CXCR4 inhibitors generated by linking low affinity peptides

Zhang, C., Huang, L., Zhu, R., Meng, Q., Zhu, S., Xu, Y., Zhang, H., Fang, X., Zhang, X., Zhou, J., et al. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.03.056 · Cited by 13

SARS-CoV-2 Portrayed against HIV: Contrary Viral Strategies in Similar Disguise

Duerr, R., Crosse, K. M., Valero-Jimenez, A. M., & Dittmann, M. (2021) · Microorganisms · doi:10.3390/microorganisms9071389 · Cited by 12

Advancing the preclinical study of comorbid neuroHIV and substance use disorders: Current perspectives and future directions

Namba, M. D., Xie, Q., & Barker, J. M. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.07.021 · Cited by 10

Increased HIV-1 sensitivity to neutralizing antibodies by mutations in the Env V3-coding region for resistance to CXCR4 antagonists

Hikichi, Y., Yokoyama, M., Takemura, T., Fujino, M., Kumakura, S., Maeda, Y., Yamamoto, N., Sato, H., Matano, T., & Murakami, T. (2016) · Journal of General Virology · doi:10.1099/jgv.0.000536 · Cited by 11

Novel Applications of Nanotechnology in Controlling HIV and HSV Infections

Sai Akilesh, M., & Wadhwani, A. D. (2020) · Current Drug Research Reviews · doi:10.2174/2589977512999201124121931 · Cited by 11

Applications of Nanoparticles for Herpes Simplex Virus (HSV) and Human Immunodeficiency Virus (HIV) Treatment

Obisesan, O. S., Katata‐Seru, L., Mufamadi, M. S., & Mufhandu, H. T. (2021) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2021.3074 · Cited by 11

HIV-1 Hijacking of Host ATPases and GTPases That Control Protein Trafficking

Tavares, L., Januário, Y. C., & daSilva, L. L. P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.622610 · Cited by 12

Owl monkey CCR5 reveals synergism between CD4 and CCR5 in HIV-1 entry

Nahabedian, J. F., Sharma, A., Kaczmarek, M., Wilkerson, G. K., Sawyer, S. L., & Overbaugh, J. M. (2017) · Virology · doi:10.1016/j.virol.2017.09.018 · Cited by 11

An Overview of Antiretroviral Agents for Treating HIV Infection in Paediatric Population

Melo, R., Lemos, A., Preto, A. J., Bueschbell, B., Matos‐Filipe, P., Barreto, C. A. V., de Almeida, J. G., Silva, R. D. M., Correia, J. D. G., & Moreira, I. S. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180904123549 · Cited by 11

Complexation of peptide epitopes with G4-PAMAM dendrimer through ligand diffusion molecular dynamic simulations

Bello, M., Rodríguez-Fonseca, R. A., & Correa‐Basurto, J. (2019) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2019.107514 · Cited by 11

Phenotypic and Genotypic Co-receptor Tropism Testing in HIV-1 Epidemic Region of Tanzania Where Multiple Non-B Subtypes Co-circulate

Judicate, G. P., Barabona, G., Kamori, D., Mahiti, M., Tan, T. S., Ozono, S., Mgunya, A. S., Kuwata, T., Matsushita, S., Sunguya, B. F., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.703041 · Cited by 11

Analysis of HIV latent infection model with multiple infection stages and different drug classes

Alshorman, A., Alhosainat, N., & Jackson, T. L. (2022) · Journal of Biological Dynamics · doi:10.1080/17513758.2022.2113828 · Cited by 10

Advances in glycan-specific biomimetic molecular recognition and its biomedical applications

Li, W., & Liu, Z. (2025) · Chemical Communications · doi:10.1039/d5cc01003a · Cited by 10

HIV-1 Entry Mechanisms: Protein-Host Receptor Interactions and Membrane Fusion Dynamics

Elalouf, A., Elalouf, H., & Maoz, H. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl37412 · Cited by 11

HIV-1 gp120 and tobacco smoke synergistically disrupt the integrity of the blood-brain barrier

Bhalerao, A., & Cucullo, L. (2022) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2022.151271 · Cited by 10

Assembly and characterization of gp160-nanodiscs: A new platform for biochemical characterization of HIV envelope spikes

Nakatani-Webster, E., Hu, S.-L., Atkins, W. M., & Catalano, C. E. (2015) · Journal of Virological Methods · doi:10.1016/j.jviromet.2015.09.011 · Cited by 10

Adenoviral vectors elicit humoral immunity against variable loop 2 of clade C HIV-1 gp120 via “Antigen Capsid-Incorporation” strategy

Gu, L., Krendelchtchikova, V., Krendelchtchikov, A., Farrow, A. L., Derdeyn, C. A., & Matthews, Q. L. (2015) · Virology · doi:10.1016/j.virol.2015.10.010 · Cited by 10

Derivation and Characterization of a CD4-Independent, Non-CD4-Tropic Simian Immunodeficiency Virus

Swanstrom, A. E., Haggarty, B., Jordan, A. P. O., Romano, J., Leslie, G. J., Aye, P. P., Marx, P. A., Lackner, A. A., Prete, G. Q. D., Robinson, J. E., et al. (2016) · Journal of Virology · doi:10.1128/jvi.02851-15 · Cited by 10

Preparation of Phosphonooxymethyl Prodrugs of HIV-1 Attachment Inhibitors

Leahy, D. K., & Pack, S. K. (2013) · Organic Process Research & Development · doi:10.1021/op400225q · Cited by 10

Enhanced potency of bivalent small molecule gp41 inhibitors

Sofiyev, V., Kaur, H., Snyder, B. A., Hogan, P. A., Ptak, R. G., Hwang, P. K., & Gochin, M. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.11.010 · Cited by 10

Virus-Host Gene Interactions Define HIV-1 Disease Progression

Mónaco, D. C., Ende, Z. S., & Hunter, E. (2017) · Current topics in microbiology and immunology · doi:10.1007/82_2017_33 · Cited by 10

In Silico Identification of Novel Aromatic Compounds as Potential HIV-1 Entry Inhibitors Mimicking Cellular Receptor CD4

Andrianov, A. M., Nikolaev, G. I., Kornoushenko, Y. V., Xu, W., Jiang, S., & Tuzikov, A. V. (2019) · Viruses · doi:10.3390/v11080746 · Cited by 10

Human Acute and Chronic Viruses: Host-Pathogen Interactions and Therapeutics

Hoffman, M., Chigbu, D. I., Crumley, B. L., Sharma, R. K., Pustylnikov, S., Crilley, T. A., Ginwala, R., Loonawat, R., Joseph, J., Sales, D., et al. (2020) · Springer eBooks · doi:10.1007/978-3-030-33946-3_1 · Cited by 10

Brief Report: Impact of Methamphetamine Use and Rectal STIs on Systemic and Rectal Mucosal Inflammation

Blair, C. S., Fulcher, J. A., Cho, G. D., Gorbach, P. M., SHOPTAW, S. J., & Clark, J. L. (2022) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000003143 · Cited by 10

Bivalent Ligand Aiming Putative Mu Opioid Receptor and Chemokine Receptor CXCR4 Dimers in Opioid Enhanced HIV-1 Entry

Ma, H., Wang, H., Li, M., Barreto‐de‐Souza, V., Reinecke, B. A., Gunta, R., Zheng, Y., Kang, G., Nassehi, N., Zhang, H., et al. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.0c00444 · Cited by 10

Determination of Binding Affinity of Antibodies to HIV-1 Recombinant Envelope Glycoproteins, Pseudoviruses, Infectious Molecular Clones, and Cell-Expressed Trimeric gp160 Using Microscale Thermophoresis

Basu, S., Gohain, N., Kim, J., Trinh, H. V., Choe, M., Joyce, M. G., & Rao, M. (2023) · Cells · doi:10.3390/cells13010033 · Cited by 9

Single domain antibodies from camelids in the treatment of microbial infections

Greve, H. D., & Fioravanti, A. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1334829 · Cited by 9

Deep Thought on the HIV Cured Cases: Where Have We Been and What Lies Ahead?

Xiao, Q., He, S., Wang, C., Zhou, Y., Zeng, C., Li, J., Liu, T., Li, T., Quan, X., Wang, L., et al. (2025) · Biomolecules · doi:10.3390/biom15030378 · Cited by 11

Virtual Screening, Biological Evaluation, and 3D-QSAR Studies of New HIV-1 Entry Inhibitors That Function via the CD4 Primary Receptor

Zhang, C., Zhang, H., Huang, L., Zhu, S., Xu, Y., Zhang, X., Schooley, R. T., Yang, X., Huang, Z., & An, J. (2018) · Molecules · doi:10.3390/molecules23113036 · Cited by 9

Molecular Mechanisms of HIV Entry

Wilen, C. B., Tilton, J. C., & Doms, R. W. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0980-9_10 · Cited by 215

Membrane organization of virus and target cell plays a role in HIV entry

Dumas, F., Preira, P., & Salomé, L. (2014) · Biochimie · doi:10.1016/j.biochi.2014.08.015 · Cited by 18

Mechanisms and Specificity of HIV Entry into Host Cells

Düzgüneş, N. (1991) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-5976-0 · Cited by 8

Cell surface receptors, virus entry and tropism of primate lentiviruses

Clapham, P. R., & McKnight, Á. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-8-1809 · Cited by 255

HIV entry: a game of hide-and-fuse?

Melikyan, G. B. (2013) · Current Opinion in Virology · doi:10.1016/j.coviro.2013.09.004 · Cited by 128